Advance Federal Tax

) With regards to the deliverables for the arrangement described in the case study, there are a few different deliverables described. The first is the research and development agreement between SolvGen and Careway. The second is the license and distribution agreement between SolvGen and Careway. These agreements are both written, contractually binding arrangements that are within the scope of multiple element arrangements. However, this does not apply to the nonrefundable milestone payments from Careway, because they are payments relating to research and development deliverables that are accounted for under the milestone method of revenue recognition.

2) The milestone payments received to date by SolvGen should be recognized as revenue over the expected period of the related research program. A portion of each milestone payment is recognized when the milestone is achieved based on the percentage of the research term that has elapsed. Any balance is recognized over the remaining research term. Each milestone payment should be evaluated separately to determine whether the milestone is substantive. It’s contingent upon achievement of a substantive milestone in its entirety in the period in which the milestone is achieved. Policies for recognizing deliverable consideration can be applied consistently to similar deliverables or units of accounting.

3) The milestone payments received to date by SolvGen should be recognized as revenue over the expected period of the related research program. A portion of each milestone payment is recognized when the milestone is achieved based on the percentage of the research term that has elapsed. Any balance is recognized over the remaining research term. Each milestone payment should be evaluated separately to determine whether the milestone is substantive. It’s contingent upon achievement of a substantive milestone in its entirety in the period in which the milestone is achieved. Policies for recognizing...

When should the...